(Q36915537)

17 August 2017

1 reference

title

Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature (English)

1 reference

nephrogenic systemic fibrosis

17 August 2017

1 reference

Wahba IM

1

1 reference

17 August 2017

Simpson EL

series ordinal

2

1 reference

17 August 2017

White K

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

16 August 2007

1 reference

American Journal of Transplantation

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

10

1 reference

17 August 2017

2425-2432

1 reference

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Nephrogenic systemic fibrosis: a clinicopathologic study of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Nephrogenic fibrosing dermopathy: the first 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Gadolinium deposition in nephrogenic fibrosing dermopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01941.X

10.1111/J.1600-6143.2007.01941.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference